Q1

Showing 7 posts of 37 posts found.

Lundbeck moves ahead in Q1

May 3, 2013
Sales and Marketing Lexapro, Lundbeck, Otsuka, Q1

Lundbeck’s sales and profit increase in the first three months of 2013 was due largely to one-off payments it received, …

‘Solid’ start for Novartis

April 30, 2013
Sales and Marketing Novartis, Q1, sales

Novartis’ sales of pharma products were unchanged in the first quarter of 2013 at $7.9 billion, with pricing flat, the …

lilly_corporate_hq

Zyprexa decline hits Lilly

April 26, 2013
Sales and Marketing Q1, lilly, zyprexa

Loss of exclusivity on Lilly’s blockbuster antipsychotic Zyprexa in 2011 continued to hit the company hard in the first quarter …

tamiflu

Cancer drugs boost Roche

April 12, 2013
Sales and Marketing Cancer, Q1, Roche

Roche saw overall sales rise 6% year-on-year in the first three months of this year on the back of a …

DSM sees green shoots for pharma unit in Q1

May 8, 2012
Business Services, Manufacturing and Production, Sales and Marketing DSM, Kensey Nash, NSCLC, Q1, Sinochem

DSM said its pharmaceutical business unit posted ‘weak’ financials in the first quarter of 2012, although revenues rose and there …

Brennan bows to pressure and quits AstraZeneca

April 26, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, David Brennan, Q1, pharma

AstraZeneca’s chief executive David Brennan is to step down from his post following mounting dissatisfaction with his leadership. Brennan, who …

Novartis Q1 earnings slide down

April 26, 2012
Sales and Marketing Novartis, Q1, Sandoz, generics, gilenya

Generic competition and problems at a US plant were among the reasons why Novartis’ sales and profit dipped in the …

Latest content